Factors Influencing Longevity of Humoral Response to SARS-CoV-2 Vaccination in Patients with End Stage Kidney Disease Receiving Renal Replacement Therapy

COVID-19 has severely affected the population of patients with end stage renal disease. Current data have proved a two-dose vaccination schedule against SARS-CoV-2 to be effective among dialyzed patients. There are limited data on the longevity and modulating factors of humoral response after vaccin...

Descripción completa

Detalles Bibliográficos
Autores principales: Glowinska, Irena, Labij-Reduta, Barbara, Juzwiuk, Jerzy, Lukaszewicz, Magdalena, Pietruczuk, Adam, Poplawska, Agata, Daniluk-Jamro, Anna, Kakareko, Katarzyna, Rydzewska-Rosolowska, Alicja, Naumnik, Beata, Koc-Zorawska, Ewa, Zorawski, Marcin, Hryszko, Tomasz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9457318/
https://www.ncbi.nlm.nih.gov/pubmed/36078913
http://dx.doi.org/10.3390/jcm11174984

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9457318/
https://www.ncbi.nlm.nih.gov/pubmed/36078913
http://dx.doi.org/10.3390/jcm11174984

Ejemplares similares